Key Record Dates
ClinicalTrials.gov Identifier: | NCT05091346 |
---|---|
Brief Title: | A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors |
First Submitted : | October 14, 2021 |
First Submitted that Met QC Criteria : | October 14, 2021 |
First Posted : | October 25, 2021 |
Last Update Submitted that Met QC Criteria : | March 10, 2023 |
Last Update Posted : | March 13, 2023 |